ArticleToxicology reports2026
Favorable outcome in a neonate with methamphetamine, tobacco, and alcohol exposure with Hypoxic Ischemic Encephalopathy managed using therapeutic hypothermia.
Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report details the management of a neonate with moderate Hypoxic Ischemic Encephalopathy (HIE) and prenatal polysubstance exposure. Born at 36 weeks gestation following maternal methamphetamine, tobacco, and alcohol use, the infant suffered a placental abruption. Therapeutic cooling was initiated at three hours of life for 72 h. While urine toxicology confirmed methamphetamine exposure, Neonatal Abstinence Syndrome (NAS) scores remained below the pharmacological threshold. Despite limitations in advanced neurophysiological monitoring common in resource-limited settings, the infant's recovery was successfully managed through diligent clinical monitoring, supportive care, and early multidisciplinary neurodevelopmental follow-up. Notably, an average Battelle Developmental Inventory score administered at 5 months of age showed promise, but long-term monitoring is needed given the patient's high-risk prenatal history.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.